BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17885787)

  • 1. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.
    Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2007 Nov; 31(11):2085-91. PubMed ID: 17885787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
    Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
    Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effectiveness of Prophylactic Modified Neck Dissection for Reducing the Development of Lymph Node Recurrence of Papillary Thyroid Carcinoma.
    Ito Y; Miyauchi A; Kudo T; Kihara M; Fukushima M; Miya A
    World J Surg; 2017 Sep; 41(9):2283-2289. PubMed ID: 28429089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.
    Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2004 May; 28(5):498-501. PubMed ID: 15085396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.
    Ito Y; Miyauchi A
    World J Surg; 2007 May; 31(5):905-15. PubMed ID: 17219265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?
    Ducoudray R; Trésallet C; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    World J Surg; 2013 Jul; 37(7):1584-91. PubMed ID: 23564213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
    Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
    World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection.
    Lee YM; Sung TY; Kim WB; Chung KW; Yoon JH; Hong SJ
    Br J Surg; 2016 Jul; 103(8):1020-5. PubMed ID: 27121346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.
    Sugitani I; Fujimoto Y; Yamada K; Yamamoto N
    World J Surg; 2008 Nov; 32(11):2494-502. PubMed ID: 18784956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
    Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
    Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid cancer: role of the lymph node dissection.
    Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
    G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
    Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.